Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

Author： Obulesu M. Venu R. Somashekhar R.

ISSN： 0364-3190

Source： Neurochemical Research, Vol.36, Iss.8, 2011-08, pp. : 1329-1335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies

By Sorrentino G. Bonavita V.

Neurological Sciences, Vol. 28, Iss. 2, 2007-04 ,pp. : 63-71

Springer Publishing Company

Access to resources Recommend Favorite

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Lewy body pathology in Alzheimer’s disease

By Kotzbauer Paul Trojanowski John Lee Virginia

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 225-232

Humana Press, Inc

Access to resources Recommend Favorite

Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer’s Disease

Current Alzheimer Research, Vol. 11, Iss. 7, 2014-01 ,pp. : 655-663

Bentham Science Publishers

Access to resources Recommend Favorite